Unusual absence of endothelium-dependent or -independent vasodilatation to purines or pyrimidines in the rat renal artery

Kidney International

Volumn 64, Issue 4, 2003, Pages 1389-1397

  Knight, Gillian E ^a   Oliver Redgate, Rachel ^a   Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ATP; Constriction; Dilatation; P2X; P2Y; Rat; Renal artery

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; NORADRENALIN; PRAZOSIN; PURINE DERIVATIVE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIMIDINE DERIVATIVE; RECEPTOR SUBTYPE; URIDINE TRIPHOSPHATE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENAL ARTERY;

EID: 0141786855     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00233.x     Document Type: Article

References (46)

1. DRURY AN, SZENT-GYÖRGYI A: The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68:213-237, 1929
2. GREEN HN, STONER HB, editors: Biological Actions of Adenine Nucleotides, London, H.K. Lewis & Co., Ltd., 1950
3. BURNSTOCK G: Purinergic nerves. Pharmacol Rev 24:509-581, 1972
4. BURNSTOCK G: A basis for distinguishing two types of purinergic receptor, in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, edited by STRAUB RW, BOLIS L, New York, Raven Press, 1978, pp 107-118
5. BURNSTOCK G, KENNEDY C: Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-440, 1985
6. ABBRACCHIO MP, BURNSTOCK G: Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475, 1994
7. RALEVIC V, BURNSTOCK G: Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492, 1998
8. KING BF, BURNSTOCK G, BOYER JL, et al: The P2Y receptors, in The IUPHAR Compendium of Receptor Characterisation and Classification, edited by GIRDLESTONE D, London, IUPHAR Media, Ltd., 2000, pp 306-320
9. KHAKH BS, BURNSTOCK G, KENNEDY C, et al: International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118, 2001
10. BURNSTOCK G: The fifth Heymans memorial lecture - Ghent, February 17, 1990: Co-transmission. Arch Int Pharmacodyn Ther 304:7-33, 1990
11. BURNSTOCK G: Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335-342, 1999
12. RAMME D, REGENOLD JT, STARKE K, et al: Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedeberg's Arch Pharmacol 336:267-273, 1987
13. EVANS RJ, SUPRENANT A: Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol 106:242-249, 1992
14. REN LM, BURNSTOCK G: Prominent sympathetic purinergic vasoconstriction in the rabbit splenic artery: Potentiation by 2,2′-pyridylisatogen tosylate. Br J Pharmacol 120:530-536, 1997
15. STARKE KJ, VON KÜGELGEN I, BULLOCH JM, et al: Nucleotides as cotransmitters in vascular sympathetic neuroeffector transmission. Blood Vessels 28:19-26, 1991
16. BURNSTOCK G: Noradrenaline and ATP: Cotransmitters and neuromodulators. J Physiol Pharmacol 46:365-384, 1995
17. MATHIESON JJI, BURNSTOCK G: Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur J Pharmacol 118:221-229, 1985
18. BRIZZOLARA A, BURNSTOCK G: Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br J Pharmacol 103:1206-1212, 1991
19. SAÏAG B, BODIN P, SHACOORI V, et al: Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells. Endothelium 2:279-285, 1995
20. 2-purinoceptors in the cardiovascular system. Circulation 84:1-14, 1991
21. RALEVIC V, BURNSTOCK G: Discrimination by PPADS between endothelial P2Y- and P2Y-purinoceptors in the rat isolated mesenteric arterial bed. Br J Pharmacol 118:428-434, 1996a
22. RALEVIC V, BURNSTOCK G: Relative contribution of P2U-and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed. Br J Pharmacol 117:797-1802, 1996b
23. INSCHO EW, MITCHELL KD, NAVAR LG: Extracellular ATP in the regulation of renal microvascular function. FASEB J 8:319-328, 1994
24. FERGUSON DR, JOHNSON BI, PRICE N: Responses of the pig isolated renal artery to transmural electrical stimulation and drugs. Br J Pharmacol 84:879-882, 1985
25. VON KÜGELGEN I, KRUMME B, SCHAIBLE U, et al: Vasoconstrictor responses to the P2X-purinoceptor agonist β,γ-methylene-L-ATP in human cutaneous and renal blood vessels. Br J Pharmacol 116:1932-1936, 1995
26. RUMP LC, OBERHAUSER V, VON KÜGELGEN I: Purinoceptors mediate vasodilatation by nitric oxide dependent and independent mechanisms. Kidney Int 54:473-481, 1998
27. WILDMAN SS, KING BF, BURNSTOCK G: Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH. Br J Pharmacol 123:1214-1220, 1998
28. LLEWELLYN-SMITH IJ, SONG ZM, COSTA M, et al: Ultrastructural localization of nitric oxide synthase immunoreactivity in guinea-pig enteric neurons. Brain Res 577:337-342, 1992
29. LLEWELLYN-SMITH IJ, PILOWSKY P, MINSON JB: The tungstate-stabilized tetramethylbenzidine reaction for light and electron microscopic immunocytochemistry and for revealing biocytin filled neurons. J Neurosci Methods 46:27-40, 1993
30. KENNEDY C: ATP as a cotransmitter in perivascular sympathetic nerves. J Auton Nerv Syst 16:337-340, 1996
31. SCHWARTZ DD, MALIK KU: Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J Pharmacol Exp Ther 250:764-771, 1989
32. OBERHAUSER V, VONEND O, RUMP LC: Neuropeptide Y and ATP interact to control renovascular resistance in the rat. J Am Soc Nephrol 10:1179-1185, 1999
33. HANSEN MA, DUTTON JL, BALCAR VJ, et al: P2X (Purinergic) receptor distribution in rat blood vessels. J Auton Nerv Sys 75:147-155, 1999
34. 1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274:F799-F804, 1998
35. LEWIS CJ, EVANS RJ: Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries. J Auton Nerv Sys 81:69-74, 2000
36. 4 receptors in rat vascular smooth muscle: An in situ hybridization RT-PCR study. J Vasc Res 35:179-185, 1998
37. JOHNSON CD, HUDSON S, MARSHALL JM: The pH sensitivity of the ATP purinoceptor-mediated component of sympathetically evoked vasoconstriction in rat tail vasculature in vivo. J Physiol 112P:528, 2000
38. JIANG F, LI CG, RAND MJ: Mechanisms of nitric oxide-dependent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries. Br J Pharmacol 130:1191-1200, 2000
39. + release in isolated renal arteries of rats. Br J Pharmacol 132:1558-1564, 2001
40. MARTIN PL, POTTS AA: The endothelium of the rat renal artery plays and obligatory role in A2 adenosine receptor-mediated relaxation induced by 5′-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine. J Pharmacol Exp Therap 270:893-899, 1994
41. 1 receptors. J Med Chem 41:183-190, 1998
42. SAÏAG B, MILON D, ALLAÍN H, et al: Constriction of the smooth muscle of the rat tail and femoral arteries and dog saphenous vein in induced by uridine triphosphate via 'pyrimidinoceptors', and by adenosine triphosphate via P2x purinoceptors. Blood Vessels 27:352-364, 1990
43. MCLAREN GJ, BURKE KJ, BUCHANAN P, et al: Evidence that ATP acts at two sites to evoke contraction in the rat isolated tail artery. Br J Pharmacol 124:5-12, 1998
44. LÓPEZ C, SÁNCHEZ M, HIDALGO A, et al: Pharmacological evidence for a receptor mediating sustained nucleotide-evoked contractions of rat aorta in the presence of UTP. Eur J Pharmacol 349:225-235, 1998
45. BURNSTOCK G: Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-373, 2002
46. 2 purinergic receptors. J Pharmacol Exp Therap 265:334-338, 1993